The Combination of Morphology and Surface Chemistry Defines the Immunological Identity of Nanocarriers in Human Blood
Authors:
- 13 June 2021
- journal article
- research article
- Published by Wiley in Advanced Therapeutics
- Vol. 4 (8) , 2100062
Abstract
Upon exposure to blood, a corona of proteins adsorbs to nanocarrier surfaces to confer a biological identity that interfaces with the immune system. While the nanocarrier surface chemistry has long been the focus of protein corona formation, the influence of nanostructure has remained unclear despite established influences on biodistribution, clearance, and inflammation. Here, combinations of nanocarrier morphology and surface chemistry are engineered to i) achieve compositionally distinct protein coatings in human blood and ii) control protein‐mediated interactions with the immune system. A library of nine PEGylated nanocarriers differing in their combination of morphology (spheres, vesicles, and cylinders) and surface chemistry (methoxy, hydroxyl, and phosphate) are synthesized to represent properties of therapeutic and biomimetic delivery vehicles. Analysis by quantitative label‐free proteomic techniques reveal that specific surface chemistry and morphology combinations adsorb unique protein signatures from human blood, resulting in differential complement activation and elicitation of distinct proinflammatory cytokine responses. Furthermore, nanocarrier morphology is shown to primarily influence uptake and clearance by human monocytes, macrophages, and dendritic cells. This comprehensive analysis provides mechanistic insights into rational design choices that impact the immunological identity of nanocarriers in human blood, which can be leveraged to engineer drug delivery vehicles for precision medicine and immunotherapy.Keywords
All Related Versions
This publication has 81 references indexed in Scilit:
- Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophagesInternational Journal of Nanomedicine, 2012
- Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered NanoparticlesPLOS ONE, 2011
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- Nanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProceedings of the National Academy of Sciences of the United States of America, 2008
- Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle BiodistributionMolecular Pharmaceutics, 2008
- Nanoparticle Interaction with Biological Membranes: Does Nanotechnology Present a Janus Face?Accounts of Chemical Research, 2007
- Shape effects of filaments versus spherical particles in flow and drug deliveryNature Nanotechnology, 2007
- Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteinsNature Biotechnology, 2004
- A Comparative Study of the Relationship Between Protein Structure and β-Aggregation in Globular and Intrinsically Disordered ProteinsJournal of Molecular Biology, 2004
- Studies of serum protein adsorption at phospholipid surfaces in relation to intravenous drug deliveryColloids and Surfaces A: Physicochemical and Engineering Aspects, 1999